Drug intelligence / Profile preview

carbadox

Development stage
Unknown
Lead developer
Phibro Animal Health
Modality
Small Molecules
Administration
Oral
01

Overview

**Carbadox** is a synthetic antimicrobial and antiparasitic drug used exclusively in veterinary medicine, specifically for swine. Its primary indications are the control of swine dysentery (caused by Brachyspira hyodysenteriae), control of bacterial swine enteritis (including salmonellosis and necrotic enteritis due to Salmonella enterica), and as an aid in preventing infections by large roundworm (Ascaris suum) and nodular worm (Oesophagostomum). It is also used to improve feed efficiency and promote weight gain in growing pigs[1][3][8]. Carbadox acts by interfering with bacterial DNA synthesis, likely through DNA alkylation, which leads to prevention of bacterial growth and cell death. It has no analogs in human medicine and is not considered important for human antimicrobial therapy[3][5]. Carbadox is genotoxic, mutagenic, and has been demonstrated to be carcinogenic and teratogenic in animal studies[1][5][7].

Brand names
Mecadox
Other names
carbadox
02

Targets

Neuraminidase

Beyond the preview

Go deeper on carbadox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbadox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call